Publications

​

2026​

• Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus

• Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study

• Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study

• Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study

 

2025

• Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus

• Association of Lupus Low Disease Activity State And Remission With Reduced Organ Damage And Flare in Systemic lupus erythematosus Patients With High Disease Activity

• Time trends of variability in disease activity in systemic lupus erythematosus

• Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort

• Demographic and clinical characterstics of patient with SLE across 5 registeries - The LupusNet federated data network

• Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohort

• Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort

• Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active

• Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study

• Predictors of damage accrual by organ domain in systemic lupus erythematosus

​​

2024​

• Sub-optimal use of anti-malarial therapy for SLE in the Asia Pacific region: observations from the Asia Pacific lupus cohort

• Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus

• Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus

• Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

• Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study 

• Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

• SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus—an analysis of anti-double-stranded DNA monitoring

​

2023​

• Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus 

• Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study

• Prevalence, Determinants and Outcomes of Target Attainment in SLE Patients with Clinically Active Disease in a Large Multinational Prospective Lupus Cohort

 

2022

• 'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study

• Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

• Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study

• Patterns of Medication Use in Systemic Lupus Erythematosus - A Multi-Centre Cohort Study

 

2021​

• Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study

2020

• Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

• COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration

2019

• Development of the Asia Pacific Lupus Collaboration cohort

• Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

• Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

• Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus

• Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

• Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

• Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

2017

• Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

• Does expert opinion match the operational definition of the lupus low disease activity state (LLDAS)? A case based construct validity study

2016

• Definition and Initial Validation of a Lupus Low Disease Activity State (LLDAS)

• Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort

​

​